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Despite a reduction in cardiovascular mortality in recent
decades in industrialized countries, the prevalence of cardiovas-
cular diseases is still increasing because of lack of control of
cardiovascular risk factors, including physical inactivity [1]. Indeed,
a large number of epidemiological and clinical studies have shown
that regular physical activity (PA) reduces the main modiﬁable
cardiometabolic risks, which leads to premature death due to
cardiovascular disease [2]. The direct health beneﬁts of regular
exercise are now irrefutable, and exercise appears as efﬁcient as
pharmacologic strategies to control chronic diseases [3]. Therefore,
it seems that ‘‘exercise is medicine’’ [4].
Thus, a dose of global exercise could be prescribed as much as a
dose of any drug. This exercise dose could be deﬁned by frequency,
intensity, and duration, which is frequently summarized by energy
expenditure. Studies have reported different amounts of PA to
induce health beneﬁts, and recommendations have evolved over
the past 2 decades. Speciﬁc PA guidelines have emerged in an
attempt to combat various chronic conditions such as hyperten-
sion, diabetes, dyslipidemia, and obesity that contribute to
cardiometabolic risk. As a consequence, we have conﬂicting
messages that are also potentially confusing to the public, arising
as advice from clinicians or through the mainstream media or
publicity. The recommended dose of PA reported by research
studies depends on the chronic disease in question and on
judgment criteria (e.g., mortality, physical ﬁtness, symptoms, or
quality of life), but they share a similar objective of prescribing
adequate levels of PA to prevent cardiovascular disease.
During the 1970s and 1980s, prospective epidemiological
studies estimated the amount of PA necessary to move from a
sedentary lifestyle to a physically active one in the general
population [5,6]. These studies found that the difference between
the two lifestyles was equivalent to an active energy expenditure
ranging from 1000 to 1500 kcal per week. The public health
recommendation in most developed countries is to walk for an
equivalent of at least 30 min per day, most days of the week (i.e.,
150 min per week) [7], which approximately corresponds to the
extra 1000 kcal energy expenditure leading to health beneﬁts. This
has likely led to the simple and effective message ‘‘30 minutes of
walking per day’’ heard in national communication campaigns.
In a recent paper in The Lancet, Wen et al. reported the results
from a very large observational study (n = 416,175) that 15 min/
day of moderate-intensity PA, or 90 min/week of moderate-
intensity PA, reduced all-cause mortality by 14%, cancer mortality
by 10%, and mortality from cardiovascular disease by 20% [8]. We
agree that this advice is simple and probably easily achievable. The
knowledge that as little as 15 min/day of exercise on most days ofhttp://dx.doi.org/10.1016/j.rehab.2015.05.002
1877-0657/ 2015 Elsevier Masson SAS. All rights reserved.the week can substantially reduce a person’s risk of dying could
encourage many more to include a small amount of PA in their
busy lives [9]. However, in the Wen et al. study, the beneﬁts of PA
followed a dose–response curve, which clearly indicated that
‘‘although a small amount of PA is good, more is better’’.
Regarding the worldwide problem of obesity, the dose of
exercise required to lose weight and to lower cardiovascular risk is
not well determined, even if it can be summarized as ‘‘even a little
is good, but more may be better!’’ for patients and clinicians
[10,11].
Finally, all of these studies do not deal with the logic of the
development of socio-ecological dimensions that recommend
including doses of PA during each day as soon as possible, with no
speciﬁc exercise plan. This lifestyle could be fostered by
environmental and economic measures that favor active means
of transport. This plan is supported by the study of Fan et al. (2013),
who showed that even with slightly lower total energy expendi-
ture, the repetition of short but high-intensity doses of energy
expenditure in everyday life was more effective in helping men and
women lose weight than was lower-intensity exercise, whatever
the duration [12]. This study supports the public health promotion
message that ‘‘every minute counts.’’
Moreover, Fitzgerald et al. (2015) found that daily sedentary
time is positively associated with predicted 10-year coronary heart
disease risk among mobility-limited older adults [13]. Therefore,
sedentary periods during the day (sitting position) should be
limited, because the duration, not the intensity, of the activity
appears inversely associated with the occurrence of coronary
events in older adults. This recommendation can be summarized
simply as ‘‘avoid the seat.’’
In addition, a recent study underlined that running even at
relatively low doses (5 to 10 min/day), below the current
minimum guidelines of vigorous-intensity aerobic activity, was
sufﬁcient for substantial beneﬁts that represented a 30% and 45%
decrease in total and cardiovascular mortality, respectively (Lee
et al.) [14]. This ﬁnding agreed with The Copenhagen City Heart
Study that monitored 1098 healthy joggers and 3950 non-joggers,
also healthy, from 2001 to 2013 [15]: the lowest mortality was
associated with light jogging, at low intensity, 2 to 3 times/week.
The mortality in intensive joggers and non-joggers was not
statistically different. These studies support the message ‘‘train
cool, live long’’.
In speciﬁc populations with high cardiovascular risk, the
question of the intensity of the exercise sessions, as well as their
duration and frequency, is becoming a key issue [16]. Although
intensity can improve exercise capacity, it can also increase the risk
of adverse events occurring during exercise. However, intensity
ranges for the prescription of aerobic training are included in most
guidelines and publications regarding secondary prevention and
cardiac rehabilitation, even if they remain very wide, with no
speciﬁcation for a proper individualization [17,18].
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in cardiac patients, the growing interest in high-intensity interval
training (HIIT) in high-risk patients led to a number of studies in
this area [19]. The beneﬁts of HIIT in patients referred for cardiac
rehabilitation programs have now been clearly demonstrated [19]
with a low risk of cardiovascular events [20]. Following the
promising studies of Rognmo et al. and Wisloff et al. in cardiac
patients, [21,22] Tjonna et al. (2008) reported the same beneﬁts of
HIIT in patients with metabolic syndrome and high cardiovascular
risk [23]. HIIT improved peak maximal oxygen consumption (VO2),
reduced the number of cardiometabolic risk factors, reduced the
prevalence of metabolic syndrome and improved endothelial
function and glucose metabolism to a greater degree than did
continuous, long and low-intensity exercise [19]. More recently, in
a systematic review and meta-analysis, Weston et al. (2013)
showed that HIIT signiﬁcantly increased cardiorespiratory ﬁtness,
by a factor of almost 2 as compared with moderate-intensity
continuous training in patients with lifestyle-induced chronic
cardiometabolic diseases [24]. Likewise, Hollekim-Strand et al.
(2014) recently showed that diastolic and systolic function, ﬂow-
mediated dilation, haemoglobin A1c level, high-sensivity C-
reactive protein level and peak VO2 were signiﬁcantly improved
in patients with type 2 diabetes and diastolic dysfunction after
12 weeks of HIIT as compared with moderate-intensity exercise
[25].
These improvements reported after sessions of HIIT have led
certain authors, such as Moholdt et al. (2013), to convey another
message in the management of coronary heart disease, namely
‘‘the higher the intensity, the better’’ [26]. This message seems to
be supported by the Ismail et al. (2013) systematic review and
meta-analysis of patients with heart failure [27]. This study
showed a positive relationship between increased exercise
intensity and cardiorespiratory ﬁtness and an association with
increased adherence and safety. Moreover, Moholdt et al. (2012)
showed that HIIT led to quantiﬁable improvements in peak oxygen
uptake in a large cohort of patients (n = 89) with myocardial
infarction. In these rather frail and weak patients, the message to
clinicians could be that HIIT is the standard mode of exercise as
recommended in recent guidelines [18].
Generally, the 4 meta-analyses published on this subject since
2013 corroborate this message [24,27–29]. However, their
conclusions were based on randomized controlled studies with
small numbers of participants and varying HIIT protocols.
Therefore, if public health messages arising from this scientiﬁc
literature advocate that the intensity of effort is the determining
factor in beneﬁts gained, pleasure derived and risks incurred
during physical activity, we must remain cautious because a
number of other studies, with larger cohorts, have had contradic-
tory ﬁndings [30,31]. However, even these studies have their
drawbacks in that they used HIIT training protocols that were
arbitrarily based on heart rate, peak power or other less clinically
functional criteria [32].
In May 2013, a study was published in PLOS One by researchers
from the Norwegian University of Science and Technology who
investigated the minimum amount of exercise needed to acquire
acceptable health beneﬁts in apparently healthy overweight men
[33]. One group followed the most widely used HIIT protocol
consisting of 4  4 min at 90% of maximal heart rate (HRmax)
interspersed with 3 min active recovery at 70% HRmax (4-AIT), and
the other group performed only a single-dose protocol of 4 min at
90% HRmax (1-AIT). The authors found that a single short dose of
high-intensity physical activity performed 3 times/week may be a
time-efﬁcient strategy to improve peak VO2 and reduce blood
pressure and fasting glucose in previously inactive but otherwise
healthy, middle-aged, overweight patients. If the results are the
same whether a person exercises 4 or 16 min, perhaps the nextmessage could be ‘‘the shorter, the more intense, the better’’. If the
main limitation in PA adherence is lack of time, the 1-AIT could be
implemented in new mass campaigns that aim to improve public
health. In addition, Coquart et al. (2008) showed that HIIT was
perceived to be less arduous than moderate continuous PA in obese
women with and without diabetes [34]. Thus, the message could
be ‘‘the more intense and shorter, the more enjoyable’’.
The concepts cited above corroborate the results of 3 studies of
obese patients from the Montreal Heart Institute [35,36]. Patients
participated in high-intensity interval training (repeated 15- to 30-
sec doses at high intensity over 20 min) 2 to 3 times/week
combined with counselling for a Mediterranean diet. Waist
circumference was signiﬁcantly reduced, ventricular repolariza-
tion parameters were improved, systolic blood pressure was
reduced and aerobic ﬁtness was improved over the ﬁrst 9 months
of the study, and blood sugar levels were improved in patients with
diabetes. The authors developed an optimized and time-efﬁcient
model of HIIT. The originality of the study lies in the fact that
training represented 10 min of real exercise [37]. In other words,
the message could be ‘‘low volume, high intensity, and individual-
ized training’’.
In conclusion, even though the key messages of these studies
appear to be conﬂicting, one way to summarize the prescription of
global PA might be efﬁcacy, safety and cost-effectiveness.
Therefore, public health policies could encourage behaviours that
are both healthy and appropriate to prevent cardiovascular
disease. This move requires thought and consensus on speciﬁc
messages to be given to the public, the training of teams who
supervise PA and the creation of ﬂowcharts to help physicians and
healthcare professionals choose and implement optimal exercise
protocols. This protocol should begin with radical politically
motivated prevention by increasing the amount of time spent
participating in sports at school. In addition, medical training
should include appropriate education components, so that future
clinicians can properly appreciate the ‘‘epidemiological swing’’
induced by the aging of the population and chronic disease burden.
Indeed, medical students spend years learning how to prescribe
drugs, but they are rarely instructed on the value of exercise
prescription for various medical conditions or how to prescribe it.
As well, later, when chronic disease is established, therapeutic
patient education is essential to optimize the therapeutic alliance
around PA, regardless of the key messages. Given that different
exercise parameters (i.e., large amount or high intensity) have
different levels of efﬁcacy on health indicators, the message must
be adapted to the patient’s speciﬁc needs. This message has to be
even more tailored to patients with comorbidities. Indeed,
regardless of the strategy used with each population and the
message delivered, advice should be centred around the efﬁcacy,
security and pleasure that can be derived from PA. Exercise
prescribers should be adequately trained to adapt the parameters
of PA to each clinical population.
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